Common Contracts
5 similar Option Agreement contracts by Regen Biologics Inc
OPTION AGREEMENTOption Agreement • April 5th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
This Option Agreement (“Option Agreement”) is made as of the 30th day of March, 2007 (the “Effective Date”), by and between ReGen Biologics, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Holder”).
OPTION AGREEMENTOption Agreement • April 5th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
This Option Agreement (“Option Agreement”) is made as of the 5th day of April, 2007 (the “Effective Date”), by and between ReGen Biologics, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Holder”).
OPTION AGREEMENTOption Agreement • March 8th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
This Option Agreement (“Option Agreement”) is made as of the 2nd day of March, 2007 (the “Effective Date”), by and between ReGen Biologics, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Holder”).
OPTION AGREEMENTOption Agreement • December 6th, 2006 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
This Option Agreement (“Option Agreement”) is made as of the 30th day of November, 2006 (the “Effective Date”), by and between ReGen Biologics, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Holder”).
OPTION AGREEMENTOption Agreement • December 6th, 2006 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
This Option Agreement (“Option Agreement”) is made as of the 1st day of December, 2006 (the “Effective Date”), by and between ReGen Biologics, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and the undersigned investor (together with its successors and permitted assigns, the “Holder”).
